Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Fresenius Medical Care AG (FMS) over the last 17 years, with Q2 2025 value amounting to -$166.4 million.

  • Fresenius Medical Care AG's Capital Expenditures fell 99.19% to -$166.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$751.4 million, marking a year-over-year decrease of 614.76%. This contributed to the annual value of -$732.0 million for FY2024, which is 169.27% down from last year.
  • According to the latest figures from Q2 2025, Fresenius Medical Care AG's Capital Expenditures is -$166.4 million, which was down 99.19% from -$149.4 million recorded in Q1 2025.
  • In the past 5 years, Fresenius Medical Care AG's Capital Expenditures registered a high of -$140.1 million during Q1 2024, and its lowest value of -$307.7 million during Q4 2021.
  • In the last 5 years, Fresenius Medical Care AG's Capital Expenditures had a median value of -$180.0 million in 2022 and averaged -$193.5 million.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Capital Expenditures surged by 3302.86% in 2022, and later plummeted by 2798.79% in 2024.
  • Fresenius Medical Care AG's Capital Expenditures (Quarter) stood at -$307.7 million in 2021, then soared by 33.03% to -$206.1 million in 2022, then decreased by 24.78% to -$257.1 million in 2023, then grew by 3.18% to -$249.0 million in 2024, then soared by 33.17% to -$166.4 million in 2025.
  • Its last three reported values are -$166.4 million in Q2 2025, -$149.4 million for Q1 2025, and -$249.0 million during Q4 2024.